Influenza A virus virulence factors

Influenza A virus constitutes a serious health problem being responsible for a quarter to half a million deaths annually, depending on the pathogenicity of the circulating strain, prior immunity, and effectiveness of the administered vaccine.

Pathogenesis determinants include the intrinsic properties of IAV strains, and their interplay with host defence mechanisms. The Amorim lab found a specific interaction between influenza A virus and the complement system. With renewed interest caused by implementation of successful complement-targeting therapies, the complement is not just a pathogen killer, but a key player in immunity. It bridges innate and adaptive responses, and orchestrates the intensity of immunological and inflammatory processes by communicating with immune cells. Interactions are beginning to be fully appreciated, and their identification is crucial, as excess complement activation is associated with severe outcomes in many infections. Our goal is to understand the mechanisms by which the virus modulates the function of the complement, contributing to better define how complement communicates with other biological systems.

Updated on 08 january 2020

Cookies settings

Cookies Selection

This website uses cookies to improve your browsing experience, security, and its website performance. We may also use cookies to share information on social media and to display messages and advertisements personalised to your interests, both on our website and in others.